載入...
Pulmonary function in patients with trophoblastic disease treated with low-dose methotrexate.
The Sheffield Trophoblastic Disease Centre treats about 25 patients with persistent trophoblastic disease each year. A total of 75% of patients are classified as low risk according to the Charing Cross Hospital prognostic scoring system and receive methotrexate (MTX) 50 mg, i.m., on days 1, 3, 5, 7...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
1997
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2228140/ https://ncbi.nlm.nih.gov/pubmed/9374387 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|